本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

奧麥羅製藥

8.42
+0.56007.12%
盤後8.420.00000.00%16:23 EDT
成交量:37.31萬
成交額:312.19萬
市值:4.88億
市盈率:-3.71
高:8.54
開:8.02
低:7.94
收:7.86
資料載入中...

公司資料

公司名字:
奧麥羅製藥
交易所:
NASDAQ
成立時間:
1994
員工人數:
198
公司地址:
The Omeros Building,201 Elliott Avenue West,Seattle,Washington,United States
郵編:
98119
電話:
傳真:
- -
簡介:
Omeros Corporation在華盛頓成立。該公司正在推進多個開發項目,重點關注與補體系統相關的疾病和紊亂,補體系統是一組專門的蛋白質,可防止侵襲性病原體以及體內受損細胞,是人體免疫系統的重要組成部分。當觸發時,補體的各種成分協同產生免疫反應,對抗感染並清除受損或死亡的細胞,維持身體系統的健康功能。然而,補體系統的失調(即過度激活或激活不足)可能是有害的,並且與感染和非感染性疾病的脆弱性增加有關,包括自身免疫性疾病、慢性炎症、血栓性微血管病和癌症。

董事

名稱
職位
Gregory A. Demopulos
President, Chief Executive Officer and Chairman of the Board
Arnold C. Hanish
Director
Diana T. Perkinson
Director
Leroy E. Hood
Director
Peter A. Demopulos
Director
Rajiv Shah
Director
Thomas F. Bumol
Director
Thomas J. Cable
Director

股東

名稱
職位
Gregory A. Demopulos
President, Chief Executive Officer and Chairman of the Board
Bruce Meiklejohn
Vice President, Chemistry, Manufacturing and Controls
Catherine A. Melfi
Vice President, Regulatory Affairs & Quality Systems and Chief Regulatory Officer
Christopher S. Bral
Vice President, Nonclinical Development
Daniel G. Kirby
Vice President, Chief Commercial Officer
George A. Gaitanaris
Vice President, Science and Chief Scientific Officer
J. Steven Whitaker
Vice President, Chief Medical Officer
Michael A. Jacobsen
Vice President, Finance, Chief Accounting Officer and Treasurer
Peter B. Cancelmo
Vice President, General Counsel and Secretary
Timothy M. Duffy
Vice President, Business Development
Tina Quinton
Vice President, Patents